Steven A. Kriegsman is Director at RXI PHARMACEUTICALS CORP (RXII). They have made 3 open-market trades across 2 companies since 2009, most recently 2020-08-07.
CIK 0001197482
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $51K since 2012, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALE | SELL | 2014-01-23 | 2014-04-09 | $5.92 | $888K | -48.6% | -1.4% | -1.4% |
| GALE | SELL | 2014-01-17 | 2014-01-22 | $6.52 | $2.9M | -48.6% | -1.4% | -1.4% |
| CYTR | BUY | 2012-02-22 | 2012-02-24 | $0.32 | $51K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-08-19 | 2009-08-20 | $3.13 | $28K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-07-01 | 2009-07-06 | $4.33 | $13K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-29 | 2009-07-01 | $4.53 | $21K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-25 | 2009-06-29 | $4.57 | $28K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-23 | 2009-06-25 | $4.64 | $5K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-19 | 2009-06-23 | $4.70 | $14K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-17 | 2009-06-19 | $4.67 | $12K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-15 | 2009-06-17 | $4.74 | $8K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-11 | 2009-06-15 | $5.01 | $18K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-09 | 2009-06-11 | $4.98 | $26K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-05 | 2009-06-09 | $5.02 | $24K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-03 | 2009-06-05 | $5.02 | $25K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-06-01 | 2009-06-03 | $5.11 | $67K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-05-28 | 2009-06-01 | $5.71 | $23K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-05-26 | 2009-05-28 | $6.00 | $29K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-05-11 | 2009-05-13 | $4.93 | $3K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-05-07 | 2009-05-11 | $4.67 | $25K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-05-05 | 2009-05-07 | $4.28 | $41K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-05-01 | 2009-05-05 | $4.79 | $24K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-04-29 | 2009-05-01 | $4.82 | $35K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-04-27 | 2009-04-29 | $4.71 | $14K | N/A | N/A | N/A |
| RXII | SELL · 10b5-1 | 2009-04-23 | 2009-04-27 | $4.72 | $23K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.